Valeant Pharmaceuticals to Present at J.P. Morgan 29th Annual Health Care Conference

January 10, 2011

MISSISSAUGA, Ontario, Jan. 10, 2011 /PRNewswire via COMTEX/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced members of its senior management team will make a presentation at the J.P. Morgan 29th Annual Health Care Conference on Wednesday, January 12, 2011 at 10:30 a.m. PT. The conference will be held at the Westin St. Francis in San Francisco, Calif.

A live webcast and audio archive of the presentation will be available on the company's Web site at http://www.valeant.com/. Click on Investor Relations, and then the link to Events and Presentations. Participants should allow approximately five to ten minutes prior to the presentation's start time to visit the site and download any streaming media software needed to listen to the Internet webcast. The webcast can also be accessed through the following URL: http://jpmorgan.metameetings.com/webcasts/healthcare11/directlink?ticker=VRX

About Valeant

Valeant Pharmaceuticals International, Inc. (NYSE: VRX/TSX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology, dermatology and branded generics. More information about Valeant can be found at http://www.valeant.com/.

(Logo: http://photos.prnewswire.com/prnh/20101025/LA87217LOGO)

Laurie Little

Valeant Pharmaceuticals

949-461-6002

Annual Report

2015 Annual Report

The right products
The right philosophy.
record organic growth.

View All